We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KEY:NYSEKeyCorp Analysis

Data as of 2026-04-12 - not real-time

$21.46

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

KeyCorp trades at $21.46, well below its DCF fair value of $43.89, indicating a sizable valuation gap. The stock’s P/E of 14.1 is comfortably under the industry average of 17.1, while the dividend yield of 3.82% and a payout ratio of ~54% suggest the dividend is currently sustainable. Technicals show a bullish MACD (line above signal) and a neutral trend with the 20‑day SMA (19.97) just below the price, while the RSI at 64 points to modest upward momentum without being overbought. Support sits at $18.73 and resistance at $21.70, placing the current price near the top of its short‑term range, and volume is decreasing, hinting at a potential pause. Volatility is elevated at 28% over the past 30 days and beta of 1.16 signals higher market sensitivity, typical for regional banks. The company’s solid operating margin (33.6%) and profit margin (26.1%) support earnings stability, and the forward EPS of $2.13 suggests earnings growth ahead. Analysts average a “Buy” rating with a target median price of $23, implying ~12% upside. Overall, the combination of undervaluation, attractive dividend, and supportive fundamentals makes KEY a compelling candidate for investors seeking value and income.
However, the high debt level, decreasing volume, and sector‑specific risks warrant careful monitoring, especially in a volatile rate environment. Short‑term traders may wait for a break above $21.70 to confirm momentum, while longer‑term investors can benefit from the dividend and potential price appreciation as the market re‑prices the underlying value.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD histogram
  • Price near resistance with upside potential
  • Strong dividend yield

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervaluation relative to DCF and peers
  • Analyst consensus target median above current price
  • Sustainable dividend supporting total return

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Fundamental strength: solid margins and earnings growth
  • Long‑run valuation gap (DCF fair value)
  • Consistent dividend income over time

Key Metrics & Analysis

Financial Health

Revenue Growth131.50%
Profit Margin26.10%
P/E Ratio14.1
ROE9.48%
ROA0.98%
P/B Ratio1.3
Op. Cash Flow$2.2B
Industry P/E17.1

Technical Analysis

TrendNeutral
RSI64.8
Support$18.73
Resistance$21.70
MA 20$19.97
MA 50$20.84
MA 200$19.35
MACDBullish
VolumeDecreasing
Fear & Greed Index87.09

Valuation

Fair Value$43.89
Target Price$24.07
Upside/Downside12.17%
GradeUndervalued
TypeValue
Dividend Yield3.82%

Risk Assessment

Beta1.17
Volatility28.09%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.